Welcome to our dedicated page for abrdn Income Credit Strategies Fund news (Ticker: $ACP), a resource for investors and traders seeking the latest updates and insights on abrdn Income Credit Strategies Fund stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect abrdn Income Credit Strategies Fund's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of abrdn Income Credit Strategies Fund's position in the market.
abrdn Global Infrastructure Income Fund (ASGI) announced a 33% increase in distribution rate, marking a 68% increase since December 2023. The Fund's Board approved an increase in annualized distribution rate from 9% to 12%, with the distribution rate on share price now at 13.4%. This marks the third increase in distribution rate since the Fund's launch in July 2020. The new distribution policy aims to provide sustainable cash distribution to shareholders and potentially reduce the Fund's discount to NAV.
abrdn Life Sciences Investors (HQL) and abrdn Healthcare Investors (HQH) have announced a 20% increase in distribution rates, marking a 50% increase since January 2024. The distribution rates for both funds will commence with the distributions payable on June 28, 2024. The Funds intend to maintain the increased Managed Distribution Policy for at least the next 12 months. The Investment Adviser's outlook on the healthcare sector is optimistic, with expectations of strong returns due to demographic trends, innovation, and macroeconomic factors.